journal article·2024-05-14Open access

Process Optimization of Scaled-Up Production and Biosafety Evaluation of the Dimethyl-Dioctadecyl-Ammonium Bromide/Poly(lactic acid) Nano-Vaccine

Hengye Yang, Yuan Gao, Meijuan Liu, Juan Ma, Qun Lu

Abstract

Nano-adjuvant vaccines could induce immune responses and enhance immunogenicity. However, the application and manufacturing of nano-adjuvant is hampered by its challenging scale-up, poor reproducibility, and low security. Therefore, the present study aimed to optimize the preparation nanoparticles (NPs) using FDA-approved biopolymer materials poly(lactic acid) (PLA) and cationic lipid didodecyl-dimethyl-ammonium bromide (DDAB), develop the scale-up process, and evaluate the stability and biosafety of it. The optimum preparation conditions of DDAB/PLA NPs on a small scale were as follows: DDAB amount of 30 mg, aqueous phase volume of 90 mL, stirring rate at 550 rpm, and solidifying time of 12 h. Under the optimum conditions, the size of the NPs was about 170 nm. In scale-up preparation experiments, the vacuum rotary evaporation of 6 h and the Tangential flow ultrafiltration (TFU) method were the optimum conditions. The results suggested that DDAB/PLA NPs exhibited a uniform particle size distribution, with an average size of 150.3 ± 10.4 nm and a narrow polydispersity index (PDI) of 0.090 ± 0.13, coupled with a high antigen loading capacity of 85.4 ± 4.0%. In addition, the DDAB/PLA NPs can be stored stably for 30 days and do not have side effects caused by residual solvents. For biosafety, the acute toxicity experiments showed good tolerance of the vaccine formulation even at a high adjuvant dose. The local irritation experiment demonstrated the reversibility of muscular irritation, and the repeated toxicity experiment revealed no significant necrosis or severe lesions in mice injected with the high-dose vaccine formulation. Overall, the DDAB/PLA NPs exhibit potential for clinical translation as a safe candidate vaccine adjuvant.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · Advanced Drug Delivery Systems · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China

Key Laboratory of Forest Plant Ecology, Ministry of Education, Heilongjiang Provincial Key Laboratory of Ecological Utilization of Forestry-Based Active Substances, College of Chemistry, Chemistry Engineering and Resource Utilization, Northeast Forestry University, Harbin 150040, China

College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China

Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China

Funding

R&D Program of Beijing Municipal Education Commission

References (35)

Show source-provided references
1. Induction of Adaptive Immune Response by Self-Aggregating Peptides10.1080/14760584.2018.1507742 ↗
2. Goetz, M., Thotathil, N., Zhao, Z., and Mitragotri, S. (2024). Vaccine Adjuvants for Infectious Disease in the Clinic. Bioeng. Transl. Med.10.1002/btm2.10663 ↗
3. Targeted and Controlled Drug Delivery System Loading Artersunate for Effective Chemotherapy on CD44 Overexpressing Cancer Cells10.1007/s12272-016-0738-4 ↗
4. Surfactant Interactions with Biomembranes and Proteins10.1039/cs9922100127 ↗
5. Zhang, T., He, P., Guo, D., Chen, K., Hu, Z., and Zou, Y. (2023). Research Progress of Aluminum Phosphate Adjuvants and Their Action Mechanisms. Pharmaceutics, 15.10.3390/pharmaceutics15061756 ↗
6. In-Depth Review of Delivery Carriers Associated with Vaccine Adjuvants: Current Status and Future Perspectives10.1080/14760584.2023.2238807 ↗
7. Analysis of Genes Regulated by the Transcription Factor Luman Identifies Apoa4 as a Target Gene in Dendritic Cells10.1016/j.molimm.2011.12.003 ↗
8. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices-United States, 202310.15585/mmwr.mm7234a4 ↗
9. Park, H.-J., Ko, H.L., Won, D.-H., Hwang, D.-B., Shin, Y.-S., Kwak, H.-W., Kim, H.-J., Yun, J.-W., and Nam, J.-H. (2019). Comprehensive Analysis of the Safety Profile of a Single-Stranded Rna Nano-Structure Adjuvant. Pharmaceutics, 11.10.3390/pharmaceutics11090464 ↗
10. Evolving Pharmacovigilance Requirements with Novel Vaccines and Vaccine Components10.1136/bmjgh-2020-003403 ↗
11. Molecular Engineering Tools for the Development of Vaccines against Infectious Diseases: Current Status and Future Directions10.1080/14760584.2023.2227699 ↗
12. Systemic Delivery of Blood-Brain Barrier-Targeted Polymeric Nanoparticles Enhances Delivery to Brain Tissue10.3109/1061186X.2015.1065833 ↗
13. Surface Modification of Poly(Lactic Acid) Nanospheres Using Hydrophobically Modified Dextrans as Stabilizers in an O/W Emulsion/Evaporation Technique
14. Synthesis, Characterization and Evaluation of Novel Triblock Copolymer Based Nanoparticles for Vaccine Delivery against Hepatitis B10.1016/j.jconrel.2009.02.010 ↗
15. Antimicrobial Additives for Poly(Lactic Acid) Materials and Their Applications: Current State and Perspectives10.1007/s00253-018-9220-1 ↗
16. Pegylated and Functionalized Polylactide-Based Nanocapsules: An Overview10.1016/j.ijpharm.2023.122760 ↗
17. Surfactant-Free Anionic Pla Nanoparticles Coated with Hiv-1 P24 Protein Induced Enhanced Cellular and Humoral Immune Responses in Various Animal Models10.1016/j.jconrel.2006.02.006 ↗
18. Fabrication and Characterization of Ddab/Pla-Alginate Composite Microcapsules as Single-Shot Vaccine10.1039/C8RA00013A ↗
19. Potential Hepatitis B Vaccine Formulation Prepared by Uniform-Sized Lipid Hybrid Pla Microparticles with Adsorbed Hepatitis B Surface Antigen10.1021/acs.molpharmaceut.8b00722 ↗
20. Preventing Surgery-Induced Nk Cell Dysfunction and Cancer Metastases with Influenza Vaccination
21. Cationic Polymer Modified Plga Nanoparticles Encapsulating Alhagi Honey Polysaccharides as a Vaccine Delivery System for Ovalbumin to Improve Immune Responses10.2147/IJN.S203072 ↗
22. Strong Antibody Responses Induced by Protein Antigens Conjugated onto the Surface of Lecithin-Based Nanoparticles10.1016/j.jconrel.2009.08.023 ↗
23. The New Era of Vaccines: The “Nanovaccinology”
24. One-Pot Facile Preparation of Peg-Modified Plga Nanoparticles: Effects of Peg and Plga on Release Properties of the Particles10.1016/j.colsurfa.2015.01.011 ↗
25. Block Copolypeptide Nanoparticles for the Delivery of Ocular Therapeutics10.1002/mabi.201400471 ↗
26. Renukaradhya, G.J., Wang, W., Huang, B., Jiang, T., Wang, X., Qi, X., Gao, Y., Tan, W., and Ruan, L. (2012). Robust Immunity and Heterologous Protection against Influenza in Mice Elicited by a Novel Recombinant Np-M2e Fusion Protein Expressed in E. coli. PLoS ONE, 7.10.1371/journal.pone.0052488 ↗
27. A Paper-Based Platform for Long-Term Deposition of Nanoparticles with Exceptional Redispersibility, Stability, and Functionality10.1002/ppsc.201800483 ↗
28. Plga Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury10.1007/s12035-015-9235-x ↗
29. Preparing for Pandemic Vaccination: An International Policy Agenda for Vaccine Development10.1057/palgrave.jphp.3200008 ↗
30. (2020). Chinese Pharmacopoeia.
31. The Adjuvant Pcep Induces Recruitment of Myeloid and Lymphoid Cells at the Injection Site and Draining Lymph Node10.1016/j.vaccine.2014.03.014 ↗
32. Phenotypic Analysis of Ovine Antigen Presenting Cells Loaded with Nanoparticles Migrating from the Site of Vaccination10.1016/j.ymeth.2013.02.008 ↗
33. Local Immune Responses to Vaa DNA Vaccine against Listonella Anguillarum in Flounder (Paralichthys olivaceus)10.1016/j.molimm.2021.03.012 ↗
34. Evaluation of Acute and Subacute Toxicity of Sodium Taurodeoxycholate in Rats10.1080/01480545.2019.1609493 ↗
35. Systemic Cytokine Storm in Severe Eosinophilic Dermatitis10.1093/qjmed/hcv056 ↗